14d
News Medical on MSNNew compound Z526 combats cancer-associated cachexia in preclinical modelsIn a recent study, researchers demonstrated that Z526, a novel dithiocarbamate-like compound, mitigates cancer-associated cachexia (CAC) both in vitro and in vivo.
Jan. 31, 2025 — In a new study, researchers have determined that a protein called NF-kB c-Rel can intensify the symptoms of psoriasis when activated by signals from the body's immune system.
The final targets of TLRs are DNA-binding transcription factors (such as NF-kB and IRFs) that activate specific patterns of gene expression in the nucleus. The signaling system is conserved in the ...
What makes the cells differ from one another is that different genes in that DNA are either turned on or off in each type of cell. Take a typical cell, such as a red blood cell. Each gene within ...
Hosted on MSN1mon
A potential pathway may guide new therapies for inflammatory bowel disease and other inflammatory diseasesDr. Ma adds, "Our results show that BB1 prevented the TNF-α increase in intestinal tight junction permeability via a toll-like receptor (TLR)-2 signal transduction pathway inhibition of NF-kB p50 ...
Disparate pathogenic mechanisms complicate precision-medicine efforts to treat diffuse large B-cell lymphoma (DLBCL), the most common lymphoma diagnosis. Though potentially curable with frontline ...
In cancer-associated cachexia, elevated TNF-α and IL-6 exacerbate muscle and fat loss by regulating multiple metabolic signaling pathways, which could be ameliorated by Z526's suppression of NF-κB ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results